hemophilia B
Manual therapy in the treatment of patients with hemophilia B and inhibitor
5
Treatment of hemophilia B: focus on recombinant factor IX
6
<p>Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study</p>
10
Molecular Characterization of the Factor IX Gene in 28 Iranian Hemophilia B Patients
5
Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion
8
GlycoPEGylated recombinant factor IX for hemophilia B in context
11
New developments in the management of moderate-to-severe hemophilia B
12
<p>Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study</p>
16
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
8
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor
7
Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients
9
Developments in the treatment of hemophilia B: focus on emerging gene therapy
11
An intragenic deletion of the factor IX gene in a family with hemophilia B
5
Hemophilia B (Christmas Disease) in a Female
6
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene
6
Unmasking Acquired hemophilia B disguised in an elderly male on Warfarin treatment – a case report and literature review.
5
To study the occurrence of inhibitors in children affected with hemophilia ‘A’ and hemophilia ‘B’ disease
5
Hemophilia B: Molecular pathogenesis and mutation analysis
12
Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes
7
Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study
5